Metabolism-based Interactions

Metabolism-Based Interactions is a type of drug-drug interaction in which the metabolic pathway of one drug is altered by another, leading to changes in the rate or extent of its biotransformation and, consequently, in its pharmacokinetic profile and pharmacological effect.

40

Publications

2.5K

Citations

127

Authors

54

Institutions

Publications per year

2017–2026

4

Authors

127

  1. DM
    D. M. JERINA

    National Institutes of Health, United States

    1 publications · 1K citations

    1

    h-index

  2. BM
    Barbara M. Davit

    United States Food and Drug Administration, United States

    1 publications · 74 citations

    1

    h-index

  3. KD
    Kevin D. Croft

    The University of Western Australia, Australia

    1 publications · 20 citations

    1

    h-index

  4. TT
    Toshiyuki Takanohashi

    Ajinomoto (Japan), Japan

    1 publications · 26 citations

    1

    h-index

  5. EW
    Edward W. Moore

    Lemuel Shattuck Hospital, United States

    1 publications · 34 citations

    1

    h-index

1–5 of 127

Venues

  1. PubMed

    Repository · 4 publications · 174 citations

    4

    h-index

  2. Science

    3 publications · 1.3K citations

    3

    h-index

  3. The Journal of Clinical Pharmacology

    2 publications · 119 citations

    2

    h-index

  4. Biochemical Pharmacology

    2 publications · 50 citations

    2

    h-index

  5. Clinical Pharmacokinetics

    2 publications · 28 citations

    2

    h-index

1–5